Cargando…
Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care
Hyperglycemia is a significant risk for mortality in COVID-19 infections and is most dramatically noted in critically ill patients. Hyperglycemia and/or diabetes are noted in approximately 30%–40% of patients admitted with COVID-19 infections. Previous studies have shown a marked increase in mortali...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686601/ https://www.ncbi.nlm.nih.gov/pubmed/33282306 http://dx.doi.org/10.1177/2050312120974174 |